Cover Image

High-Level Carbapenem Resistance among OXA-48-Producing <i>Klebsiella</i><i>pneumoniae</i> with Functional OmpK36 Alterations: Maintenance of Ceftazidime/Avibactam Susceptibility

The aim of this work was to analyze outer membrane porin-encoding genes (<i>ompK35</i> and <i>ompK36</i>) in a collection of OXA-48 producing <i>Klebsiella pneumoniae</i>, to assess the effect of porin alterations on the susceptibility to ceftazidime/avibactam, an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pilar Lumbreras-Iglesias (Author), María Rosario Rodicio (Author), Pablo Valledor (Author), Tomás Suárez-Zarracina (Author), Javier Fernández (Author)
Format:	Book
Published:	MDPI AG, 2021-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant <i>Klebsiella pneumonia</i> with blaOXA-48-like Genes
by: Al Maamon R. Abu Jaber, et al.
Published: (2024)

Synergistic Combination of Aztreonam and Ceftazidime-Avibactam-A Promising Defense Strategy against OXA-48 + NDM <i>Klebsiella pneumoniae</i> in Romania
by: Ioana Miriana Cismaru, et al.
Published: (2024)

Emergence of ST147 Klebsiella pneumoniae carrying blaNDM-7 on IncA/C2 with ompK35 and ompK36 mutations in India
by: Chaitra Shankar, et al.
Published: (2019)

The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in Zhejiang Province, China
by: Congcong Liu, et al.
Published: (2022)

Heteroresistance to Colistin in Clinical Isolates of <i>Klebsiella pneumoniae</i> Producing OXA-48
by: Irene Sánchez-León, et al.
Published: (2023)

In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Marta Palombo, et al.
Published: (2023)

Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>
by: Anthony Sophonsri, et al.
Published: (2024)

Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Lisa Allander, et al.
Published: (2022)

Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Karoline Knudsen List, et al.
Published: (2022)

Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against <i>Klebsiella pneumoniae</i> by MALDI-TOF MS
by: Camila Mörschbächer Wilhelm, et al.
Published: (2023)

The <i>Klebsiella pneumoniae</i> carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam
by: Sona Garsevanyan, et al.
Published: (2023)

In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant <i>Enterobacterales</i> Isolates from South Korea
by: Taeeun Kim, et al.
Published: (2020)

In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing <i>Klebsiella pneumoniae</i>: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations
by: Snehal Palwe, et al.
Published: (2021)

Ceftazidime-Avibactam Treatment for <i>Klebsiella pneumoniae</i> Bacteremia in Preterm Infants in NICU: A Clinical Experience
by: Andrea Marino, et al.
Published: (2023)

Resistance to Ceftazidime/Avibactam in <i>Klebsiella pneumoniae</i> KPC-Producing Isolates: A Real-Life Observational Study
by: Laura Campogiani, et al.
Published: (2023)

Ceftazidime-Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing <i>Klebsiella pneumoniae</i>
by: Li Ding, et al.
Published: (2022)

Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region
by: Rıdvan Dumlu, et al.
Published: (2024)

Bloodstream Infections Due to Wild-Type <i>Pseudomonas aeruginosa</i>: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes
by: Carlo Pallotto, et al.
Published: (2024)

In Vitro Synergism of Azithromycin Combination with Antibiotics against OXA-48-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Uthaibhorn Singkham-in, et al.
Published: (2021)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
by: George L. Daikos, et al.
Published: (2021)

OXA-48 carbapenemase-mediated ceftazidime-avibactam resistance; first reported case in Saudi Arabia's western region and review of literature
by: Y Al Dabbagh, et al.
Published: (2020)

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
by: Wei Yu, et al.
Published: (2021)

Phenotypic and Genotypic Features of <i>Klebsiella pneumoniae</i> Harboring Carbapenemases in Egypt: OXA-48-Like Carbapenemases as an Investigated Model
by: Suzan Mohammed Ragheb, et al.
Published: (2020)

First Description of Ceftazidime/Avibactam Resistance in a ST13 KPC-70-Producing <i>Klebsiella pneumoniae</i> Strain from Portugal
by: Gabriel Mendes, et al.
Published: (2022)

The Genetic Characteristics and Carbapenem Resistance Mechanism of ST307 <i>Klebsiella pneumoniae</i> Coharbouring <i>bla</i><sub>CMY-6</sub>, <i>bla</i><sub>OXA-48</sub>, and a Truncated <i>bla</i><sub>NDM-1</sub>
by: Qiucheng Shi, et al.
Published: (2022)

Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant <i>bla</i><sub>KPC-2</sub>-Producing <i>Klebsiella pneumoniae</i> Carrying <i>bla</i><sub>VEB-25</sub>
by: Charalampos Zarras, et al.
Published: (2023)

Meropenem plus Ertapenem and Ceftazidime-Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant <i>Klebsiella pneumonia</i>
by: Konstantinos Mantzarlis, et al.
Published: (2024)

Off-Label Use of Ceftazidime/Avibactam for the Treatment of Pan-Drug-Resistant <i>Klebsiella pneumoniae</i> in a Neonate: Case Report and Literature Review
by: Iliya Mangarov, et al.
Published: (2023)

Whole-Genome Sequencing and Molecular Analysis of Ceftazidime-Avibactam-Resistant KPC-Producing <i>Klebsiella pneumoniae</i> from Intestinal Colonization in Elderly Patients
by: Giulia Errico, et al.
Published: (2023)

Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
by: Wenqiang Kong, et al.
Published: (2023)

Investigating the mechanism of ceftazidime-avibactam resistance in addition to the effect of vancomycin on antibacterial resistance in carbapenem-resistant Klebsiella pneumonia
by: Nour Sherri, et al.
Published: (2020)

Association of <i>bla</i><sub>VIM-2</sub>, <i>bla</i><sub>PDC-35</sub>, <i>bla</i><sub>OXA-10,</sub> <i>bla</i><sub>OXA-488</sub> and <i>bla</i><sub>VEB-9</sub> β-Lactamase Genes with Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam in Multidrug-Resistant <i>Pseudomonas aeruginosa</i>
by: Mazen A. Sid Ahmed, et al.
Published: (2022)

Emergence of <i>bla</i><sub>NDM-5</sub> and <i>bla</i><sub>OXA-232</sub> Positive Colistin- and Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in a Bulgarian Hospital
by: Rumyana Markovska, et al.
Published: (2024)

Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis
by: Dan Li, et al.
Published: (2021)

Carbapenem-Resistant NDM and OXA-48-<i>like</i> Producing <i>K. pneumoniae</i>: From Menacing Superbug to a Mundane Bacteria; A Retrospective Study in a Romanian Tertiary Hospital
by: Dragos Stefan Lazar, et al.
Published: (2024)

Effective treatment of ventriculitis with OXA-48 carbapenem-resistant Klebseilla Pneumonia, followed by bacteremia with NDM carbapenem-resistant Klebsiella Pneumonia-case report
by: F. Mehdawi, et al.
Published: (2020)

Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of <i>Klebsiella pneumoniae</i> ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol
by: Maria Giufrè, et al.
Published: (2024)

Genomic Analysis of Ceftazidime/Avibactam-Resistant GES-Producing Sequence Type 235 <i>Pseudomonas aeruginosa</i> Isolates
by: Raúl Recio, et al.
Published: (2022)

Characterization of the First Carbapenem-Resistant <i>Pseudocitrobacter faecalis</i> Harboring <i>bla</i><sub>OXA-181</sub> in China
by: Qingyu Shi, et al.
Published: (2022)

The effect of Pd(II) and Pt(II) coordination on the affinity of avibactam to OXA-48 β-lactamase
by: Jakub Brzeski, et al.
Published: (2023)